ATE133947T1 - 2,5-diaryl-tetrahydrofurane und deren analoge als paf-antagonisten - Google Patents

2,5-diaryl-tetrahydrofurane und deren analoge als paf-antagonisten

Info

Publication number
ATE133947T1
ATE133947T1 AT90306235T AT90306235T ATE133947T1 AT E133947 T1 ATE133947 T1 AT E133947T1 AT 90306235 T AT90306235 T AT 90306235T AT 90306235 T AT90306235 T AT 90306235T AT E133947 T1 ATE133947 T1 AT E133947T1
Authority
AT
Austria
Prior art keywords
tetrahydrofuranes
diaryl
analogues
paf antagonists
alkyl
Prior art date
Application number
AT90306235T
Other languages
English (en)
Inventor
Tesfaye Biftu
Nirindar N Girotra
Mitree M Ponpipom
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE133947T1 publication Critical patent/ATE133947T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Formation Of Insulating Films (AREA)
AT90306235T 1989-06-08 1990-06-08 2,5-diaryl-tetrahydrofurane und deren analoge als paf-antagonisten ATE133947T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36292089A 1989-06-08 1989-06-08
US07/505,712 US4977146A (en) 1989-06-08 1990-04-11 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists

Publications (1)

Publication Number Publication Date
ATE133947T1 true ATE133947T1 (de) 1996-02-15

Family

ID=27001844

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90306235T ATE133947T1 (de) 1989-06-08 1990-06-08 2,5-diaryl-tetrahydrofurane und deren analoge als paf-antagonisten

Country Status (14)

Country Link
US (1) US4977146A (de)
EP (1) EP0402151B1 (de)
JP (1) JPH07100701B2 (de)
KR (1) KR910000688A (de)
AT (1) ATE133947T1 (de)
AU (1) AU636615B2 (de)
CA (1) CA2018482A1 (de)
DE (1) DE69025230D1 (de)
FI (1) FI902846A7 (de)
IL (1) IL94585A0 (de)
NO (1) NO902513L (de)
NZ (1) NZ233903A (de)
PT (1) PT94302A (de)
ZA (1) ZA904391B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114961A (en) * 1989-06-08 1992-05-19 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US5171864A (en) * 1991-08-30 1992-12-15 Allergan, Inc. Di-(5-hydroxy-2(5H)-2-oxo-4-furyl)methyl-alpha,omega alkane-dioates and N,N-bis-(5-hydroxy-2(5H)-2-oxo-4-furyl)methyl-alpha,omega-dialkanoic acid amides as anti-inflammatory agents
US5169963A (en) * 1991-08-30 1992-12-08 Allergan, Inc. Di-(5-hydroxy-2(5H)2-oxo-4-furyl)alkylmethyl-alpha,omega alkanedioates and N,N-bis-(5-hydroxy-2(5H)2-oxo-4-furyl)alkylmethyl-alpha,omega-dialkanoic acid amides as anti-inflammatory agents
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
ATE196903T1 (de) * 1992-07-13 2000-10-15 Cytomed Inc 2,5-diaryl tetrahydro-thiopene, -furane und analoge zur behandlung von entzündungs-und immunkrankheiten
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
ATE253564T1 (de) * 1994-06-27 2003-11-15 Millenium Pharmaceuticals Inc Verbindungen und verfahren zur behandlung von cardiovaskulären, inflammatorischen und das immunsystem betreffende erkrankungen
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US6444664B1 (en) 1997-04-18 2002-09-03 Nederlandse Organisatie Voor Toegepast - Natuurweten Schappelijk Onderzoek (Tno) Method for controlling the plasma level of lipoproteins to treat alzheimeris disease
EP0875247B1 (de) * 1997-04-18 2003-05-28 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Blutlipoproteinspiegel regulierendes Präparat
US6372922B1 (en) * 2001-03-27 2002-04-16 Council Of Scientific And Industrial Research Process for the production of (−) 3,4-divanillyl tetrahydrofuran
US20130184320A1 (en) 2010-10-01 2013-07-18 Basf Se Imine Compounds
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769350A (en) * 1968-12-09 1973-10-30 Hoffmann La Roche Method for making 2,3-dimethyl-1,4-bis(3,4 - hydrocarbonyloxyphenyl) - 1,4-butanedione
US4539332A (en) * 1983-11-14 1985-09-03 Merck & Co., Inc. 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
US4757084A (en) * 1984-02-29 1988-07-12 Merck & Co., Inc. 2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antagonists
IT8434016U1 (it) * 1984-03-12 1985-09-12 Zanussi A Spa Industrie Perfezionamenti ai dispositivi ammortizzatori ad attrito per lavabiancheria
US4595693A (en) * 1984-06-04 1986-06-17 Merck & Co., Inc. Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
NZ215866A (en) * 1985-04-22 1989-11-28 Merck & Co Inc 2,5-di(aryl/heterocyclyl) tetrahydro-furans and pharmaceutical compositions
GB2197650A (en) 1986-11-21 1988-05-25 Merck & Co Inc Process for preparing 2,5-diphenyl tetrahydrofurans and analogs thereof
NZ227287A (en) * 1987-12-21 1992-01-29 Merck & Co Inc 2,5-diaryl tetrahydrofurans and medicaments

Also Published As

Publication number Publication date
NO902513L (no) 1990-12-10
ZA904391B (en) 1991-03-27
CA2018482A1 (en) 1990-12-08
EP0402151A1 (de) 1990-12-12
NZ233903A (en) 1992-09-25
FI902846A0 (fi) 1990-06-07
PT94302A (pt) 1991-02-08
JPH03101670A (ja) 1991-04-26
KR910000688A (ko) 1991-01-30
JPH07100701B2 (ja) 1995-11-01
AU636615B2 (en) 1993-05-06
EP0402151B1 (de) 1996-02-07
AU5692690A (en) 1990-12-13
DE69025230D1 (de) 1996-03-21
FI902846A7 (fi) 1990-12-09
US4977146A (en) 1990-12-11
IL94585A0 (en) 1991-04-15
NO902513D0 (no) 1990-06-06

Similar Documents

Publication Publication Date Title
DE69025230D1 (de) 2,5-Diaryl-tetrahydrofurane und deren Analoge als PAF-Antagonisten
ATE240734T1 (de) Zubereitung von xanthinderivaten als feste dispersion
ZA971714B (en) Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
ATE243697T1 (de) Substitutierte heterozyclische derivate als crf antagonisten
ES2066991T3 (es) Agentes hipoglucemiantes de oxazolidinadiona.
NO951813D0 (no) Bicyklisk heterocyklisk sulfonamid og sulfonester-derivater
FI873303A0 (fi) Karbapenemderivat, foerfarande foer tillverkning av dessa och sammansaettningar innehaollande dessa. dessa.
DK0842661T3 (da) Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning
DE69813605D1 (de) Benzofuranderivate
DE69331721D1 (de) Neue carbamazepin hapten Analoge
TR199500954A1 (tr) Yeni pirokarbazoller.
OA09207A (en) Pesticidal 1-arylimidazoles.
DK0382660T3 (da) Dioxaphosphorinanforbindelser og dermed stabiliserede polyolefinmaterialer
NO942740L (no) Pyridinkarboksimidamid-forbindelse og anvendelse av samme
FI834730A0 (fi) 1-karboxialkanoylperhydro-indol-2-karboxylsyror och deras derivat
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
KR930703253A (ko) 고리형 화합물
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
ATE291015T1 (de) Alkylaminoderivate
DK0390138T3 (da) Platinkomplekser og antitumormidler med indhold deraf som aktiv bestanddel
FI853685A0 (fi) Nya n-alk(en)yl-n-(o,o-disubstituerade -tiofosforyl)-n'n'-disubstituerade glycinamider, foerfarande foer framstaellning av dessa samt kvalstergifter, insektgifter och svampgifter vilka innehaoller dessa som aktiv bestaondsdel.
SE8001620L (sv) Merkaptoacylderivat av ketosubstituerad prolin- och pipekolinsyra
ATE99306T1 (de) Antagonisten von leukotrien d4.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties